EP2788322A1 - Composition en Méthionine destinée à l'Alimentation animale - Google Patents
Composition en Méthionine destinée à l'Alimentation animaleInfo
- Publication number
- EP2788322A1 EP2788322A1 EP12810376.9A EP12810376A EP2788322A1 EP 2788322 A1 EP2788322 A1 EP 2788322A1 EP 12810376 A EP12810376 A EP 12810376A EP 2788322 A1 EP2788322 A1 EP 2788322A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- methionine
- weight
- composition according
- crystallization
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229930182817 methionine Natural products 0.000 title claims abstract description 75
- 241001465754 Metazoa Species 0.000 title claims description 15
- -1 Methionine compound Chemical class 0.000 title abstract description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 74
- 238000002425 crystallisation Methods 0.000 claims abstract description 27
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 7
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960000310 isoleucine Drugs 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims abstract description 4
- 229940099459 n-acetylmethionine Drugs 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 49
- 230000008025 crystallization Effects 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 21
- 244000005700 microbiome Species 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 11
- 238000011084 recovery Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 230000002328 demineralizing effect Effects 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 239000003674 animal food additive Substances 0.000 claims description 2
- 238000005115 demineralization Methods 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 239000006193 liquid solution Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 239000012452 mother liquor Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 description 64
- 239000002609 medium Substances 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000011552 falling film Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 102100024452 DNA-directed RNA polymerase III subunit RPC1 Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000689002 Homo sapiens DNA-directed RNA polymerase III subunit RPC1 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000204060 Streptomycetaceae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002741 methionine derivatives Chemical class 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0632—Methionine
Definitions
- the present invention relates to a novel liquid methionine composition derived from mother liquors of crystallization of methionine produced by fermentation.
- Methionine like other sulfur amino acids, is essential for cell metabolism. However, methionine is not produced by animals, which must find enough in their diet.
- Methionine can also be used as a medicine in the treatment or prevention of various diseases such as allergies or rheumatoid fevers.
- L-methionine is generally produced from fossil resources and petrochemical derivatives, in particular from acrolein, methyl mercaptan and cyanides. Obtaining the more active L enantiomer requires additional racemic resolution steps which drastically increase production costs.
- the present invention therefore relates to a new liquid methionine composition whose methionine content makes it directly usable in animal feed.
- the methionine composition according to the invention is derived from mother liquors of crystallization of methionine produced by fermentation.
- This fermentation is carried out conventionally by microorganisms grown on a suitable culture medium comprising a carbon source.
- the carbon sources are chosen from all the carbon sources likely to be metabolized by a microorganism, and in particular glucose, sucrose, monosaccharides or oligosaccharides, starch and its derivatives and their mixtures.
- composition according to the invention can be distinguished from the methionine compositions obtained by other processes by the nature and / or the content of the impurities present.
- the methionine composition according to the invention derived from mother liquors of crystallization of methionine produced by fermentation, comprises from 30% to 50% by weight of methionine and has a solids content of between 20% and 75% by weight.
- composition has a solids content of between 20% and 75% by weight
- a composition has a solids content of between 20% and 75% by weight relative to the total weight of said composition.
- a composition comprises from 30% to 50% by weight of methionine means that said composition comprises a methionine content of 30% to 50% by weight relative to the total weight of dry residues (that is to say in dry matter) of said composition. Unless otherwise indicated, the percentages are given herein by weight relative to the total weight of dry residues of the composition. In particular, the percentages of isoleucine, methionine, amino acids other than methionine and isoleucine, or N-acetyl-methionine are expressed by weight relative to the total weight of dry residues of the composition.
- the composition according to the invention is a composition which generally comprises other residues resulting from the fermentation process of methionine and in particular other amino acids.
- composition of the invention thus comprises less than 0.5% by weight of isoleucine.
- the amino acid content other than methionine and isoleucine is advantageously between 7 and 10% by weight.
- the content of N-acetyl-methionine is between 0.9 and 1.3% by weight.
- composition according to the invention also comprises and advantageously less than 5% by weight of sugar.
- the methionine composition according to the invention can be prepared by a process comprising the following steps from the fermentation medium of a methionine-producing microorganism:
- the first step of the process for preparing the methionine composition according to the invention thus consists in clarifying the fermentation medium and in removing insoluble and soluble organic impurities from said fermentation medium.
- insoluble organic impurities means biomass, proteins and residual insoluble particles.
- soluble organic impurities is meant all soluble particles contaminating the fermentation medium, including macromolecules soluble proteins and polysaccharides type.
- the methionine composition according to the invention may be derived from any method of methionine fermentation with culture of a microorganism optimized to promote the synthesis of methionine, whether it be a bacterium, yeasts or fungi (molds ).
- the microorganism is chosen from Entewbacteriaceae, Bacillaceae, Streptomycetaceae and Corynebacteriaceae.
- the microorganism is a species chosen from among the species
- Escherichia Klebsiella, Pantoea, Salmonella or Corynebacterium.
- the microorganism is selected from the species Escherichia coli or Corynebacterium glutamicum.
- the methionine composition according to the invention comes from the culture of the microorganisms described in the patent application WO 2009/043803, the content of which is incorporated herein by reference, and more particularly the microorganisms described. in the exemplary embodiments.
- the invention can be carried out using the strain of Escherichia coli of the genotype MG1655 with a Ptrc-metU PircF-cysPUWAM PtrcF-cysJJR Ptrc09-gcvTUP Ptrc36-RNAmstl7-m ⁇ ? IF Ameû ApykF ApykA ApurU (pMEIO) -thr A * 1-cysE-PgapA-met A * 11) (pCCIBAC-serB-serA-serC)
- the clarification of the medium is then carried out by any method known as such by one skilled in the art, a method chosen for example from the group consisting of flocculation, decantation, membrane techniques (microfiltration, ultrafiltration, nanofiltration and reverse osmosis ) and centrifugation.
- a method chosen for example from the group consisting of flocculation, decantation, membrane techniques (microfiltration, ultrafiltration, nanofiltration and reverse osmosis ) and centrifugation.
- soluble organic impurities is carried out by any method known as such by a person skilled in the art, a method chosen, for example, from the group consisting of ultrafiltration, heat treatment and treatment using an adsorbent. activated carbon type and enzymatic hydrolysis.
- the second step of the process for preparing the methionine composition according to the invention which can be implemented here optionally, then consists in demineralizing said clarified fermentation medium in order to eliminate the cations and anions of said medium. fermentation.
- This step can in this case be carried out by conventional electrodialysis or EDC (EURODIA ®) and / or by treatment on a cation exchange resin in H + form (Purolite ® C120, Purolite ® C150, Purolite C160 ® ...) and / or anion exchange resin (LEWATIT ® S4228, LEWATIT ® S4528, Rohm & Haas FPA91 ).
- the third step of the process for preparing the methionine composition in accordance with the invention finally consists in crystallizing methionine so as to recover the methionine in solid form, but above all, within the meaning of the invention, in order to recover and recover the waters mothers of crystallization.
- This crystallization step may be carried out by a technology selected from the group consisting of cooling crystallization, evapocrystallization crystallization and adiabatic crystallization.
- the applicant company recommends using evapocrystallization.
- the Applicant Company recommends preconcentrating the methionine solution by evaporation under vacuum using a falling film evaporator in order to approach the supersaturation.
- the pre-concentrated solution is then transferred to a draft tube crystallizer, for example, to be further concentrated and crystallized.
- the solubility of methionine at 35 ° C is about 70 g / l. Concentrating the solution at about 250 g / l, under a vacuum ensuring a temperature of 35 ° C, the recovery yield of methionine is> 70%.
- the mother liquors themselves are concentrated and recycled at the head of said crystallization process, in order to increase the crystallization yield.
- the process for preparing the methionine composition according to the invention therefore consists in adding to the process the last three subsequent complementary steps.
- the fourth step is to adjust the pH of the mother liquors of crystallization so as to be placed at a pH value ⁇ pKal of the methionine or a pH value> pKa2 of the methionine.
- This acidification operation is carried out by any method known to those skilled in the art.
- the Applicant Company recommends acidifying with 37% hydrochloric acid to a pH value of less than 2.2 (pKa of the acidic function of methionine).
- the pH of the mother liquors of crystallization is adjusted so as to set a pH value> pKa2 of the methionine by alkalinization of the mother liquors.
- the applicant company recommends alkalinizing with 50% sodium hydroxide to a pH value greater than 9.3 (pKa of the amino function of methionine).
- the fifth step may consist in filtering the solution in order to remove a precipitate consisting in particular of xanthine, and then concentrate mother liquors thus treated.
- the acidified solution is then filtered on a porosity membrane of 5 ⁇ , and concentrated until a dry matter percentage of between 20% and 75% by weight is obtained.
- the alkalized solution is filtered and concentrated until a dry matter percentage of between 20% and 75% by weight is obtained.
- the sixth step consists of recovering the liquid methionine composition according to the invention.
- composition according to the invention may advantageously be used directly in animal feed as a supplement or feed additive supplied to the animals, mixed with the feed bolus supplied to each animal, in premix, under the form of a premixed composition or extemporaneously, or independently of other foods.
- the invention therefore also relates to a food additive comprising the methionine composition according to the invention, preferably intended for animal feed.
- composition according to the invention is particularly suitable for its intake of trace elements and water to facilitate the dosing, mixing and hydration of the usual foods of the animal.
- a strain of methionine-producing Escherichia coli of genotype MG1655 contains a Pircc-metR-CysPUWAM PtrcF-cysRU Ptrc09-gcvTUP pirc36-mRmst17-metF Apytk apykA apurU (pMF101-thrA * l -cysF-PgapA-metA * ll). ) (pCClBac-serB-serA-serC), described in the patent application WO 2009/043803, is cultivated under fermentation culture conditions according to the method described in this same patent application.
- the fermentation must resulting from the implementation of said strain is purified as follows.
- the removal is carried out by tangential membrane filtration having a pore diameter of 100 nm, between 40 and 80 ° C (ceramic membrane of 3.5 mm diameter channel).
- the temperature is preferably maintained at 40 ° C. with a transmembrane pressure of 1 bar and diafiltration with 20% demineralized water.
- the average flow is 30 l / h / m 2 and the resulting permeate is clear and bright.
- This step aims to eliminate the sugars (polysaccharides) and macromolecules contained in the fermentation must.
- This elimination is carried out by ultrafiltration on a ceramic membrane having a cutoff threshold of 5 kDa.
- the filtration flow is on average 25 l / h / m 2 and about 70% of the macromolecules are retained in the retentate.
- the previous solution is pre-concentrated by evaporation of the water at 50 ° C on a WIEGAND ® type falling film vacuum evaporator.
- the concentration factor is of the order of 2 to 5 depending on the initial concentration of L-methionine.
- the pre-concentrated solution is then transferred to a forced circulation evapocrystallizer to be further concentrated and crystallized under vacuum (50 mbar) at about 35 ° C.
- the concentration factor applied in this evapocristallizer is about 3, so as to reach 240 g / l.
- the mother liquor here still contains more than 30% by dry weight of methionine. It is then chosen to acidify, filter and concentrate the mother liquors:
- a mother liquor composition according to the invention is then obtained with a solids content of 60, as shown in Table 2 below.
- This methionine composition despite its relative richness in chlorides is quite usable in animal feed, to supplement foods with methionine to obtain compositions typically comprising up to 0.5% added methionine.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1161336A FR2983870B1 (fr) | 2011-12-08 | 2011-12-08 | Composition en methionine destinee a l'alimentation animale |
PCT/FR2012/052843 WO2013083934A1 (fr) | 2011-12-08 | 2012-12-07 | Composition en Méthionine destinée à l'Alimentation animale |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2788322A1 true EP2788322A1 (fr) | 2014-10-15 |
Family
ID=47505238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12810376.9A Withdrawn EP2788322A1 (fr) | 2011-12-08 | 2012-12-07 | Composition en Méthionine destinée à l'Alimentation animale |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150045434A1 (ko) |
EP (1) | EP2788322A1 (ko) |
JP (1) | JP2015500643A (ko) |
KR (1) | KR20140103315A (ko) |
CN (1) | CN104093704A (ko) |
BR (1) | BR112014013585A2 (ko) |
FR (1) | FR2983870B1 (ko) |
IN (1) | IN2014DN04641A (ko) |
RU (1) | RU2014127661A (ko) |
WO (1) | WO2013083934A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9984075B2 (en) | 2015-10-06 | 2018-05-29 | Google Llc | Media consumption context for personalized instant query suggest |
WO2017065567A1 (en) * | 2015-10-14 | 2017-04-20 | Cj Cheiljedang Corporation | Bio-based n-acetyl-l-methionine and use thereof |
KR101821050B1 (ko) * | 2015-10-14 | 2018-03-09 | 씨제이제일제당 (주) | 바이오-기반 n-아세틸-l-메티오닌 및 이의 용도 |
KR20180093981A (ko) | 2016-01-08 | 2018-08-22 | 에보니크 데구사 게엠베하 | 발효적 생산에 의해 l-메티오닌을 생산하는 방법 |
CN109020854B (zh) * | 2018-10-17 | 2020-10-27 | 浙江工业大学 | 一种从发酵液中提取l-蛋氨酸的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4308498C2 (de) * | 1993-03-17 | 1997-01-09 | Degussa | Tierfuttermittel-Additiv auf Fermentationsbrühe-Basis, Verfahren zu dessen Herstellung und dessen Verwendung |
DE10249642A1 (de) | 2002-10-24 | 2004-05-13 | Consortium für elektrochemische Industrie GmbH | Feedback-resistente Homoserin-Transsuccinylasen mit modifiziertem C-Terminus |
WO2005007862A2 (en) * | 2003-07-08 | 2005-01-27 | Novus Internation, Inc | Methionine recovery processes |
DE10359668A1 (de) * | 2003-12-18 | 2005-07-14 | Basf Ag | Verfahren zur Herstellung von Methionin |
WO2005111202A1 (en) | 2004-05-12 | 2005-11-24 | Metabolic Explorer | Recombinant enzyme with altered feedback sensitivity |
KR100651220B1 (ko) | 2004-06-29 | 2006-11-29 | 씨제이 주식회사 | L-메씨오닌 생산 균주 및 상기 균주를 이용한l-메씨오닌의 생산방법 |
BRPI0611909A2 (pt) | 2005-06-17 | 2009-01-20 | Microbia Inc | biossÍntese aperfeiÇoada de aminoÁcido e metabàlito |
CA2615416A1 (en) | 2005-07-18 | 2007-01-25 | Basf Aktiengesellschaft | Methionine producing recombinant microorganisms |
WO2007017710A1 (en) | 2005-08-11 | 2007-02-15 | Metabolic Explorer | Process for the preparation of aspartate and derived amino acids like lysine, threonine, isoleucine, methionine, homoserine, or valine employing a microorganism with enhanced isocitrate lyase and/or malate synthase expression |
US8389250B2 (en) | 2006-01-04 | 2013-03-05 | Metabolic Explorer | Methods for producing methionine by culturing a microorganism modified to enhance production of cysteine |
WO2009043372A1 (en) | 2007-10-02 | 2009-04-09 | Metabolic Explorer | Increasing methionine yield |
JP2009292796A (ja) * | 2008-06-09 | 2009-12-17 | Sumitomo Chemical Co Ltd | メチオニンの製造方法 |
FR2951195B1 (fr) * | 2009-10-14 | 2014-01-31 | Roquette Freres | Composition riche en methionine destinee a l'alimentation animale |
-
2011
- 2011-12-08 FR FR1161336A patent/FR2983870B1/fr not_active Expired - Fee Related
-
2012
- 2012-12-07 JP JP2014545338A patent/JP2015500643A/ja active Pending
- 2012-12-07 US US14/363,078 patent/US20150045434A1/en not_active Abandoned
- 2012-12-07 KR KR1020147018981A patent/KR20140103315A/ko not_active Application Discontinuation
- 2012-12-07 WO PCT/FR2012/052843 patent/WO2013083934A1/fr active Application Filing
- 2012-12-07 BR BR112014013585A patent/BR112014013585A2/pt not_active Application Discontinuation
- 2012-12-07 EP EP12810376.9A patent/EP2788322A1/fr not_active Withdrawn
- 2012-12-07 CN CN201280060452.8A patent/CN104093704A/zh active Pending
- 2012-12-07 RU RU2014127661A patent/RU2014127661A/ru not_active Application Discontinuation
-
2014
- 2014-06-09 IN IN4641DEN2014 patent/IN2014DN04641A/en unknown
Non-Patent Citations (1)
Title |
---|
See references of WO2013083934A1 * |
Also Published As
Publication number | Publication date |
---|---|
CN104093704A (zh) | 2014-10-08 |
FR2983870A1 (fr) | 2013-06-14 |
US20150045434A1 (en) | 2015-02-12 |
BR112014013585A8 (pt) | 2017-06-13 |
IN2014DN04641A (ko) | 2015-05-08 |
BR112014013585A2 (pt) | 2017-06-13 |
RU2014127661A (ru) | 2016-02-10 |
FR2983870B1 (fr) | 2015-07-17 |
WO2013083934A1 (fr) | 2013-06-13 |
KR20140103315A (ko) | 2014-08-26 |
JP2015500643A (ja) | 2015-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI96122C (fi) | Menetelmä etanolin valmistamiseksi ja glyserolin talteenottamiseksi sivutuotteena | |
CN111447844A (zh) | 喷雾干燥的四糖 | |
WO2013083934A1 (fr) | Composition en Méthionine destinée à l'Alimentation animale | |
JPH03209339A (ja) | エタノール、グリセロール、こはく酸、乳酸、ベタイン、硫酸カリウム、l‐ビログルタミン酸、及び自由流動性デイステイラーズ乾燥粒子及び可溶物又は固体肥料の製造法 | |
US10440974B2 (en) | Methionine-rich composition for feeding animals | |
FR2619380A1 (fr) | Procede de recuperation de l-amino-acides de liqueurs de fermentation les contenant | |
EP0534865B1 (fr) | Procédé de séparation de la lysine sous la forme d'une solution aqueuse et utilisation de cette solution pour l'alimentation animale | |
US20180290961A1 (en) | Method and system for obtaining a carboxylic acid which is produced in a fermentation process | |
EP2624709B1 (fr) | Procede de fabrication de sirops de sorbitol de haute purete a partir de saccharose et utilisations | |
JP7447104B2 (ja) | 結晶性2’-フコシルラクトースを得る方法 | |
CN110776543B (zh) | 一种腺苷一次母液回收方法 | |
EP2094366A2 (fr) | Procede de purification de sialyllactose par chromatographie | |
EP2117684A1 (fr) | Procède de purification d'acides organiques | |
EP1157980B1 (fr) | Procédé de préparation d'acide lactique par évapo-cristallisation | |
CN109369731B (zh) | 一种脱除木糖生产过程中葡萄糖的方法 | |
JPH105501A (ja) | 発酵中に生産される蒸留残渣からの有用な化合物の回収方法 | |
CN105503630B (zh) | 一种提纯盐酸赖氨酸的方法 | |
CN103936798B (zh) | 提高乳糖生产的产量的方法 | |
CN110846350A (zh) | 一种苏氨酸生产和分离精制工艺 | |
FR2574790A1 (fr) | Procede de preparation d'acide glutamique a l'etat cristallise de preference sous forme de son sel sodique ou msg; acide glutamique, msg, sels et concentrat organique obtenus par ce procede | |
FR2554813A1 (fr) | Procede pour la recuperation de tryptophane optiquement actif | |
JP2024536524A (ja) | 発酵液からチロシンを製造する方法 | |
CN110846349A (zh) | 一种饲料添加剂苏氨酸的制备方法 | |
CN118414343A (zh) | LNnT的结晶 | |
BE505856A (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140605 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: METABOLIC EXPLORER |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160701 |